ChatGPT-Supported Text Messaging Program for Smoking Cessation

Launched by GEORGE WASHINGTON UNIVERSITY · Jul 14, 2025

Keywords

ClinConnect Summary

This clinical trial is testing a new way to help people quit smoking by using a special chatbot called BeFreeBot alongside an existing text message program called BeFree. The chatbot, powered by ChatGPT technology, is designed to provide extra support through text messages to encourage and guide people as they try to stop smoking. The study will compare how well people do when they use the BeFree program with the chatbot versus the program alone.

To join the trial, you need to live in the United States, be between 65 and 74 years old, have smoked at least one cigarette in the past week, and have a mobile phone that can receive text messages. Participants will get messages about the health effects of smoking for 30 days. There are no other restrictions, and the study is open to all genders. This trial is not yet recruiting, but if you join, you can expect to receive helpful text messages aimed at supporting your quit-smoking journey.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • lives in the US
• • smoked a cigarette within the last 7 days
• • has a mobile phone
• • willing to receive text messages about the health effects of smoking on their mobile phone for 30 days
• Exclusion Criteria:
• • none